Zanidatamab (ZW25)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Zanidatamab (ZW25), covering 2024-08-21 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer [Phase 3]